Our commitment to patients and their families extends beyond developing treatments; it encompasses emotional, psychological, and practical support to navigate the demanding journey of autosomal dominant polycystic kidney disease (ADPKD) patients. Our patient promise is at the core of everything we do. Read more from Lina Floren Smith, Vice President of Nephrology and Immunology business in the article below.
ADPKD is the most common genetic cause of kidney failure worldwide. The condition has a strong genetic link. The child of a parent with ADPKD has a 50 percent chance of inheriting the condition. I'm humbled to serve those living with ADPKD and bring awareness about this rare disease. #DefyLimitation